Rezolute, Inc. (NasdaqCM: RZLT)
Health Care · Biotechnology · US
$4.38
+9.23% today · -54.5% 1Y
Rezolute, Inc. (NasdaqCM: RZLT) operates in the Biotechnology industry within the Health Care sector. The company is valued at $420.64M and employs 58 people.
Over the last twelve months the share price has lost 54.5%, trading between 1.07 and 11.46.
Tweenvest scores Rezolute, Inc. across four factors: quality 36/100, value 70/100. Its strongest factor is value.
RZLT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $420.64M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.75
- Dividend yield
- —
- Beta (5Y)
- 0.54
- 52-week high
- $11.46
- 52-week low
- $1.07
- Avg volume (3M)
- —
- Shares outstanding
- 104.90M
- Employees
- 58
- Next earnings
- —
About Rezolute, Inc.
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California.
- ISIN
- US76200L3096
- Founded
- 2010
- Listed since
- Jan 14, 2013
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Egetis Therapeutics AB (publ)OM: EGTX | $425.31M | Skr10.08 | +9.80% |
| GI Innovation, Inc.KOSDAQ: A358570 | $422.52M | ₩8,820.00 | -0.56% |
| Editas Medicine, Inc.NasdaqGS: EDIT | $422.35M | $2.72 | -1.09% |
| Yantai Zhenghai Biotechnology Co., Ltd.SZSE: 300653 | $422.13M | CN¥15.94 | +1.27% |
| AP Biosciences, Inc.TPEX: 6945 | $416.39M | NT$136.00 | -1.45% |
| AbClon Inc.KOSDAQ: A174900 | $413.34M | ₩27,900.00 | +42.35% |
| Eikon Therapeutics, Inc.NasdaqGS: EIKN | $408.40M | $7.54 | +0.40% |
| Guangdong VTR Bio-Tech Co., Ltd.SZSE: 300381 | $407.32M | CN¥5.69 | +0.18% |
Figures last refreshed Oct 4, 2026.